IRIS
MIKULSKA, MALGORZATA KAROLINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.089
NA - Nord America 3.390
AS - Asia 3.252
Continente sconosciuto - Info sul continente non disponibili 599
SA - Sud America 309
AF - Africa 66
OC - Oceania 5
Totale 27.710
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 19.571
US - Stati Uniti d'America 3.160
SG - Singapore 1.163
CN - Cina 743
VN - Vietnam 555
BD - Bangladesh 454
FR - Francia 188
BR - Brasile 172
CA - Canada 97
HK - Hong Kong 93
DE - Germania 68
AR - Argentina 58
FI - Finlandia 48
GB - Regno Unito 40
IN - India 35
JP - Giappone 34
MX - Messico 34
NL - Olanda 32
IQ - Iraq 25
CR - Costa Rica 23
JM - Giamaica 21
EC - Ecuador 20
CO - Colombia 19
UA - Ucraina 18
ID - Indonesia 17
ES - Italia 16
PH - Filippine 14
TH - Thailandia 14
ZA - Sudafrica 14
CH - Svizzera 13
VE - Venezuela 13
PK - Pakistan 12
SA - Arabia Saudita 12
RU - Federazione Russa 11
TR - Turchia 11
UZ - Uzbekistan 10
AT - Austria 9
DZ - Algeria 9
KR - Corea 9
SV - El Salvador 9
TT - Trinidad e Tobago 9
GR - Grecia 8
PY - Paraguay 8
ET - Etiopia 7
KE - Kenya 7
MY - Malesia 7
PE - Perù 7
PL - Polonia 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
EG - Egitto 6
NP - Nepal 6
PT - Portogallo 6
SE - Svezia 6
AL - Albania 5
AU - Australia 5
BB - Barbados 5
GT - Guatemala 5
HN - Honduras 5
IE - Irlanda 5
LT - Lituania 5
TW - Taiwan 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
JO - Giordania 4
MA - Marocco 4
PR - Porto Rico 4
UY - Uruguay 4
BH - Bahrain 3
CW - ???statistics.table.value.countryCode.CW??? 3
KZ - Kazakistan 3
MT - Malta 3
NI - Nicaragua 3
NO - Norvegia 3
PA - Panama 3
RS - Serbia 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
BE - Belgio 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
GA - Gabon 2
HR - Croazia 2
HU - Ungheria 2
IM - Isola di Man 2
IR - Iran 2
KG - Kirghizistan 2
KY - Cayman, isole 2
LB - Libano 2
MK - Macedonia 2
MQ - Martinica 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
AG - Antigua e Barbuda 1
AI - Anguilla 1
AM - Armenia 1
AO - Angola 1
Totale 27.095
Salva come PNG Salva come JPEG
Città #
Genova 8.772
Genoa 6.750
Vado Ligure 1.721
Rapallo 1.605
San Jose 706
Singapore 579
Ashburn 368
New York 184
Ho Chi Minh City 174
Lauterbourg 165
Beijing 161
Hanoi 139
Council Bluffs 132
Milan 93
Santa Clara 92
Hong Kong 86
Bordighera 77
Los Angeles 73
Phoenix 54
Rome 53
Frankfurt am Main 52
Buffalo 51
Chicago 42
Dallas 41
Helsinki 39
Haiphong 29
Tokyo 28
Boardman 27
Naples 27
Da Nang 23
Houston 23
Bologna 20
Toronto 19
Atlanta 18
Florence 18
Orem 18
Brasília 17
Turin 17
Montreal 16
San José 16
Philadelphia 15
St Louis 15
São Paulo 15
Biên Hòa 14
San Francisco 14
Amsterdam 13
Las Vegas 13
Mexico City 12
Modena 12
London 11
Miano 11
Zurich 11
Austin 10
Bari 10
Kingston 10
Louisville 10
Miami 10
Minneapolis 10
Verona 10
Baghdad 9
Bar Harbor 9
Brooklyn 9
City of London 9
Denver 9
Dhaka 9
Hải Dương 9
Kyiv 9
Lappeenranta 9
Madrid 9
Palermo 9
Queens 9
Tampa 9
The Bronx 9
Tianjin 9
Venice 9
Bangkok 8
Can Tho 8
Springfield 8
Tashkent 8
Addis Ababa 7
Catania 7
Charlotte 7
Columbus 7
Fort Wayne 7
Marseille 7
New Orleans 7
Paris 7
Quito 7
San Antonio 7
San Salvador 7
Cincinnati 6
Colorado Springs 6
Guangzhou 6
Istanbul 6
Lima 6
Nairobi 6
Thái Nguyên 6
Warsaw 6
Athens 5
Birmingham 5
Totale 23.062
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 355
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit 253
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 251
Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil 248
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 235
Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO). 217
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 211
Use of colistin in adult patients: a cross-sectional study 205
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 204
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 203
Bacterial infections in hematopoietic stem cell transplantation recipients. 200
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 199
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 197
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 195
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 193
Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor 187
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 187
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52) 186
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 186
Bacterial infections in hematopoietic stem cell transplant recipients 185
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab 184
Bloodstream infections in critically ill patients with COVID-19 184
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 182
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 182
Biomarkers for Diagnosis and Follow-Up of Invasive Candidiasis: A Brief Review of the ECIL Recommendations 178
Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome. 178
Non-cultural methods for the diagnosis of invasive fungal disease 177
Invasive candidiasis in non-hematological patients. 176
De-Escalation and Discontinuation of Empirical Antibiotic Treatment in a Cohort of Allogeneic Hematopoietic Stem Cell Transplantation Recipients during the Pre-Engraftment Period 176
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 176
Invasive pulmonary aspergillosis in intensive care units: is it a real problem? 175
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 175
Invasive mycoses in children receiving hemopoietic SCT 171
(1-3)-β-d-glucan in cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections. 170
Pulmonary cryptococcosis with severe eosinophilia in an immunocompetent patient. 169
Bloodstream infections in neutropenic cancer patients: A practical update 169
Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. 169
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. 168
ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients 168
Multidrug-resistant bacteria in hematology patients: Emerging threats 168
Galactomannan: testing the same sample twice? 162
Pathogens in Severe Sepsis: New Paradigms for Fungi Treatment 160
Will new antimicrobials overcome resistance among Gram-negatives? 159
Piperacillin/tazobactam (TazocinTM) seems to be no longer responsible forfalse-positive results of the galactomannan assay 159
Epidemiology of viral respiratory tract infections in an outpatient haematology facility 158
Occurrence, presentation and treatment of candidemia. 156
The role of televancin in the treatment of MRSA infections in hospital 155
Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy. 154
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 154
Towards the automatic calculation of the EQUAL Candida Score: Extraction of CVC-related information from EMRs of critically ill patients with candidemia in Intensive Care Units 154
The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. 153
Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections. 153
Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature 153
Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery 153
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 153
Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report 152
Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. 151
Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). 151
Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7) 151
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 151
Galactomannan testing might be useful for early diagnosis of fusariosis. 150
2017 ECIL 7 vaccine guidelines 150
Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy 149
Voriconazole in clinical practice. 148
ECILrecommendations for the use of biological markers for the diagnosis of invasivefungal diseases in leukemic patients and hematopoietic SCT recipients 148
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 147
The Beta-d-glucan Test: Time to Re-Visit Its Utility in IFI Diagnosis 147
Mortality after bloodstream infections in allogeneichaematopoietic stem cell transplant (HSCT) recipients 145
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4) 145
Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS 145
Aggressive multiple sclerosis: a single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab 145
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): Study protocol of a retrospective multicentre international study 144
CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus. 143
Screening With Serum Galactomannan Might Be Associated With Better Outcome Than Symptom-Triggered Galactomannan Testing in Allogeneic HSCT Recipients With Invasive Aspergillosis. 142
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients. 141
Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients 140
Efficacy of daptomycin lock therapy in the treatment of bloodstream infections related to long-term catheter. 139
The skin and soft tissue infections in hematological patients 139
La Definizione di Aspergillosi 138
Evaluation of mass spectrometry-based detection of panfungal serum disaccharide for diagnosis of invasive fungal infections: Results from a collaborative study involving six European clinical centers 138
Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical 138
Manuale per la gestione delle complicanze infettive nell’emato-oncologia e trapianto di midollo osseo 137
Invasive aspergillosis: diagnosis, prophylaxis and treatment 136
Outbreak of Ralstonia pickettii bacteraemia in patients with haematological malignancies and haematopoietic stem cell transplant recipients 136
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines 136
Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT 136
The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT 136
Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on. 135
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 132
Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group 132
Management of chronic viral hepatitis in the hematological patient 132
Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7) 131
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper 130
Enterococcal bloodstream infection after hematopoietic stem cell transplant: experience of a center with a low prevalence of vancomycin-resistant enterococci. 130
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 129
A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 129
Fluoroquinolone prophylaxis during neutropenia: what can we expect nowadays? 128
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia 126
Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients 126
Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. 125
Totale 16.407
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.291
article - articoli 97.454
book - libri 414
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.423
Totale 200.582
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.626 0 0 101 233 75 168 77 414 86 179 70 223
2022/20232.076 194 139 27 181 263 285 72 138 303 132 278 64
2023/20241.477 81 168 55 189 158 217 83 107 71 47 119 182
2024/20254.357 100 324 107 304 595 426 414 733 212 219 453 470
2025/20269.017 943 307 626 706 1.030 577 1.181 478 730 829 743 867
2026/20271.718 909 388 421 0 0 0 0 0 0 0 0 0
Totale 27.710